USA Soft Gelatin Capsule Market Outlook to 2028

USA Soft Gelatin Capsule Market Overview

The USA soft gelatin capsule market is valued at USD 2.20 billion, driven by the increased demand for nutraceuticals and dietary supplements. The surge in consumer awareness about health and wellness, coupled with the growing preference for easier-to-swallow dosage forms, has fueled this demand. The soft gelatin capsule market has witnessed strong growth over the last five years, with expanding applications in pharmaceuticals, nutraceuticals, and the rising popularity of plant-based alternatives.

The USA soft gelatin capsule market is predominantly concentrated in key regions such as California, New York, and Texas. These regions host a large number of pharmaceutical and nutraceutical manufacturing companies, along with advanced research and development capabilities. California, with its biotech hubs, leads in innovation, while Texas and New York play significant roles due to their manufacturing infrastructure and robust distribution networks.

The U.S. Food and Drug Administration (FDA) approved over 100 new soft gelatin capsule formulations between 2022 and 2023, reflecting the growing interest in this dosage form. These approvals indicate the FDAs ongoing focus on ensuring the safety and efficacy of soft gelatin capsules, especially in the nutraceutical and pharmaceutical sectors. Stringent regulations around stability, bioavailability, and shelf life ensure that manufacturers consistently meet high standards.

USA Soft Gelatin Capsule Market Segmentation

By Raw Material: The USA soft gelatin capsule market is segmented by raw material into gelatin-based and non-gelatin (vegan/plant-based) capsules. Recently, gelatin-based capsules dominate due to their cost-effectiveness, widespread availability, and long-standing presence in pharmaceutical formulations. The established processes for gelatin-based capsules make them the preferred choice for drug manufacturers, especially for prescription medications.

By Application: The USA soft gelatin capsule market is also segmented by application into pharmaceuticals, nutraceuticals, cosmetics, and dietary supplements. Nutraceuticals hold a dominant market. This is largely due to the increasing demand for vitamins, omega-3 supplements, and herbal extracts in capsule form, driven by consumer preference for natural and holistic health solutions.

USA Soft Gelatin Capsule Market Competitive Landscape

The USA soft gelatin capsule market is characterized by the presence of several key players that dominate the landscape. These companies possess strong R&D capabilities, extensive distribution networks, and advanced manufacturing facilities. The competition is mainly driven by innovations in capsule formulations, including plant-based alternatives and customization options.

Company

Establishment Year

Headquarters

Revenue (USD Mn)

Production Capacity (Units)

Product Portfolio

R&D Investment (USD Mn)

Global Presence

Key Partnerships

Catalent, Inc.

1933

New Jersey

Capsugel (Lonza)

1931

New Jersey

Aenova Group

2008

Germany

Sirio Pharma

1993

China

Procaps Group

1977

Colombia

USA Soft Gelatin Capsule Industry Analysis

USA Soft Gelatin Capsule Market Growth Drivers

Increased Use in Nutraceuticals: The increasing consumer preference for nutraceuticals, including vitamins and dietary supplements, drives the demand for soft gelatin capsules. According to the National Institutes of Health, around 94 million Americans used dietary supplements in 2023, indicating rising consumption of nutraceuticals for health and wellness. Soft gelatin capsules, known for their ease of use and ability to encase liquid formulations, are favored in the nutraceutical sector. This trend aligns with the broader shift towards preventative healthcare, which is a key driver for soft gelatin capsules in the U.S. market.

Bioavailability: Soft gelatin capsules enhance bioavailability, especially for lipophilic drugs and nutraceuticals, allowing quicker absorption. For example, studies by the NIH have shown that encapsulated formulations can increase the absorption of key nutrients by up to 60%, compared to traditional tablets. This is crucial in the U.S. market, where consumer demand for effective and fast-acting supplements remains high. The high bioavailability of soft gelatin capsules is a vital selling point for pharmaceutical and nutraceutical companies alike.

Patient Preference: Patients prefer soft gelatin capsules over other forms due to their ease of swallowing and taste-masking properties. In a survey by the U.S. Food and Drug Administration (FDA), it was found that 78% of patients aged 40 and above preferred soft gelatin capsules for oral medication. This trend is increasingly influencing the formulation choices of pharmaceutical companies, pushing for growth in the soft gelatin capsule market, especially for geriatric and pediatric medications.

USA Soft Gelatin Capsule Market Restraints

Raw Material Costs: The cost of key raw materials, such as gelatin and pharmaceutical-grade glycerin, has fluctuated due to global supply chain disruptions. For example, U.S. imports of gelatin saw a 12% increase in price due to supply chain challenges from major exporting countries in 2023, according to the U.S. International Trade Commission. These price fluctuations present a challenge for manufacturers, increasing production costs and potentially impacting profit margins.

Regulatory Hurdles: The soft gelatin capsule market faces stringent regulatory frameworks from agencies like the U.S. Food and Drug Administration (FDA). Between 2022 and 2023, the FDA issued over 50 warning letters to nutraceutical manufacturers for non-compliance with labeling and quality standards. The complexity of meeting both DSHEA (Dietary Supplement Health and Education Act) requirements and new labeling standards adds another layer of difficulty, slowing down product approvals and launches.

USA Soft Gelatin Capsule Market Future Outlook

Over the next five years, the USA soft gelatin capsule market is expected to experience steady growth, driven by increasing consumer demand for plant-based and vegan capsules, coupled with innovations in encapsulation technologies. The expansion of nutraceuticals and dietary supplements, especially post-pandemic, is likely to create significant opportunities in the market. Furthermore, pharmaceutical companies are shifting toward soft gelatin capsules for drug delivery systems, contributing to the growth outlook.

Market Opportunities

Vegan Soft Gelatin Capsule Demand: Consumer demand for vegan alternatives has surged, with U.S. sales of plant-based supplements increasing by 25% in 2023, according to data from the USDA. The soft gelatin capsule industry is capitalizing on this by developing plant-based alternatives using carrageenan or hydroxypropyl methylcellulose (HPMC). This shift not only addresses ethical concerns but also caters to a growing market of vegan and vegetarian consumers, providing significant growth potential for manufacturers of vegan soft gelatin capsules.

CBD-infused Capsules: The U.S. legal cannabis market, valued at $32 billion in 2023, has led to the growing popularity of CBD-infused soft gelatin capsules, particularly for pain relief and anxiety management. According to the U.S. Department of Agriculture, CBD-based supplements account for around 10% of the total nutraceutical market. This creates an opportunity for companies to innovate within the soft gelatin capsule space by offering CBD-infused products that meet consumer demand for alternative wellness solutions.
Please Note: It will take 5-7 business days to complete the report upon order confirmation